scholarly article | Q13442814 |
P2093 | author name string | E P Trulock | |
G A Patterson | |||
T Mohanakumar | |||
V Tiriveedhi | |||
R R Hachem | |||
A Aloush | |||
P2860 | cites work | IL-17 and Th17 Cells | Q27860566 |
De novo production of K-alpha1 tubulin-specific antibodies: role in chronic lung allograft rejection | Q33551885 | ||
Anti-human leukocyte antigen antibodies and preemptive antibody-directed therapy after lung transplantation | Q34079631 | ||
Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria | Q34565524 | ||
Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection | Q34728157 | ||
Neutralizing IL-17 prevents obliterative bronchiolitis in murine orthotopic lung transplantation | Q34874203 | ||
Alloimmunity-induced autoimmunity as a potential mechanism in the pathogenesis of chronic rejection of human lung allografts | Q34970022 | ||
IL-10-producing and naturally occurring CD4+ Tregs: limiting collateral damage | Q35951526 | ||
IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants | Q36088927 | ||
Antibodies to Self-Antigens Predispose to Primary Lung Allograft Dysfunction and Chronic Rejection | Q36206262 | ||
Thymus and autoimmunity. Transplantation of the thymus from cyclosporin A-treated mice causes organ-specific autoimmune disease in athymic nude mice | Q36354777 | ||
A clinical perspective of IL-1β as the gatekeeper of inflammation | Q37869439 | ||
Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production | Q41908710 | ||
Antibodies to MHC class I induce autoimmunity: role in the pathogenesis of chronic rejection. | Q42126102 | ||
Survival differences following lung transplantation among US transplant centers. | Q42666883 | ||
Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection | Q45259438 | ||
The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult lung and heart-lung transplant report--2010. | Q45892834 | ||
A direct role for IFN-gamma in regulation of Th1 cell development. | Q45982728 | ||
Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death | Q47984672 | ||
Antivimentin antibodies are an independent predictor of transplant-associated coronary artery disease after cardiac transplantation. | Q50674616 | ||
Scientific Registry of the International Society for Heart and Lung Transplantation: introduction to the 2010 annual reports. | Q51152518 | ||
Pre- and post-transplant anti-myosin and anti-heat shock protein antibodies and cardiac transplant outcome | Q58845838 | ||
Organ-specific autoimmune disease induced in mice by elimination of T cell subsets. V. Neonatal administration of cyclosporin A causes autoimmune disease | Q69735127 | ||
Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation | Q73175430 | ||
Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome | Q79421973 | ||
CD4+25+ regulatory T cells limit Th1-autoimmunity by inducing IL-10 producing T cells following human lung transplantation | Q80061426 | ||
Severity of lymphocytic bronchiolitis predicts long-term outcome after lung transplantation | Q80670195 | ||
HLA-specific antibodies are risk factors for lymphocytic bronchiolitis and chronic lung allograft dysfunction | Q81239058 | ||
Minimal acute rejection after lung transplantation: a risk for bronchiolitis obliterans syndrome | Q81923118 | ||
Anti-Angiotensin Type 1 Receptor Antibodies Associated With Antibody Mediated Rejection in Donor HLA Antibody Negative Patients | Q82213207 | ||
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | antibody | Q79460 |
lung transplant | Q1637912 | ||
P304 | page(s) | 2164-2171 | |
P577 | publication date | 2012-05-08 | |
P1433 | published in | American Journal of Transplantation | Q4744273 |
P1476 | title | Antibodies to K-α 1 tubulin and collagen V are associated with chronic rejection after lung transplantation | |
P478 | volume | 12 |
Q92927797 | A Need for Targeted Immunosuppression after Lung Transplantation |
Q51578868 | A Promoter Polymorphism in the CD59 Complement Regulatory Protein Gene in Donor Lungs Correlates With a Higher Risk for Chronic Rejection After Lung Transplantation. |
Q47744928 | Acute rejection |
Q93127381 | An obligatory role for club cells in preventing obliterative bronchiolitis in lung transplants |
Q37654350 | Analysis of Sera of Recipients with Allograft Rejection Indicates That Keratin 1 Is the Target of Anti-Endothelial Antibodies |
Q93242498 | Anti-perlecan antibodies and acute humoral rejection in hypersensitized patients without forbidden HLA specificities after kidney transplantation |
Q50090621 | Anti-tubulin-α-1C autoantibody in systemic lupus erythematosus: a novel indicator of disease activity and vasculitis manifestations |
Q43865301 | Antibodies beyond HLA. |
Q37441785 | Antibody-mediated Rejection in Lung Transplantation |
Q26786188 | Autoimmune Liver Disease Post-Liver Transplantation: A Summary and Proposed Areas for Future Research |
Q45763669 | Autoimmune Reactivity in Graft Injury: Player or Bystander? |
Q37528715 | Autologous and Allogenous Antibodies in Lung and Islet Cell Transplantation. |
Q39356829 | B Cell-Activating Transcription Factor Plays a Critical Role in the Pathogenesis of Anti-Major Histocompatibility Complex-Induced Obliterative Airway Disease |
Q38920115 | Basement membranes and autoimmune diseases |
Q36623201 | Bronchiolitis obliterans syndrome: the Achilles' heel of lung transplantation |
Q38399493 | Characteristic patterns in the fibrotic lung. Comparing idiopathic pulmonary fibrosis with chronic lung allograft dysfunction |
Q38053174 | Chronic rejection: a significant role for Th17-mediated autoimmune responses to self-antigens |
Q52729829 | Circulating Exosomes with Distinct Properties during Chronic Lung Allograft Rejection. |
Q39015291 | Clinical and immunological relevance of antibodies in solid organ transplantation |
Q92040661 | Collagen type-V is a danger signal associated with primary graft dysfunction in lung transplantation |
Q51859649 | Community-acquired respiratory viruses after lung transplantation: common, sometimes silent, potentially lethal. |
Q48052794 | Donor-Derived Exosomes With Lung Self-Antigens in Human Lung Allograft Rejection |
Q92405144 | Early Identification of Chronic Lung Allograft Dysfunction: The Need of Biomarkers |
Q39402829 | Early clearance vs persistence of de novo donor-specific antibodies following lung transplantation. |
Q34036197 | Efficacy of extracorporeal photopheresis in clearance of antibodies to donor-specific and lung-specific antigens in lung transplant recipients. |
Q90666512 | Emphysema-associated Autoreactive Antibodies Exacerbate Post-Lung Transplant Ischemia-Reperfusion Injury |
Q41632753 | Humoral Human Lung Allograft Rejection by Tissue-Restricted Non-HLA Antibodies |
Q38246582 | Humoral immunity and complement effector mechanisms after lung transplantation |
Q36703898 | Humoral immunity and the development of obliterative bronchiolitis after lung transplantation: is there a link? |
Q40607435 | Humoral immunity in phenotypes of chronic lung allograft dysfunction: A broncho-alveolar lavage fluid analysis |
Q39121365 | Immune Responses to Tissue-Restricted Nonmajor Histocompatibility Complex Antigens in Allograft Rejection |
Q41830532 | Immune response to tissue-restricted self-antigens induces airway inflammation and fibrosis following murine lung transplantation. |
Q38110566 | Immune responses to self-antigens (autoimmunity) in allograft rejection |
Q38123309 | Interplay between immune responses to HLA and non-HLA self-antigens in allograft rejection |
Q42324374 | Long-Term Persistence of Donor Alveolar Macrophages in Human Lung Transplant Recipients That Influences Donor-Specific Immune Responses. |
Q40668499 | Lung Injury Combined with Loss of Regulatory T Cells Leads to De Novo Lung-Restricted Autoimmunity |
Q50069723 | Lung Injury and Loss of Regulatory T Cells Primes for Lung-Restricted Autoimmunity |
Q36388454 | Lung Transplantation in Cystic Fibrosis: Trends and Controversies |
Q86857643 | Lung transplantation |
Q41631328 | Lung-Restricted Antibodies Mediate Primary Graft Dysfunction and Prevent Allotolerance after Murine Lung Transplantation |
Q39217968 | Not All Antibodies Are Created Equal: Factors That Influence Antibody Mediated Rejection |
Q38645385 | Potential Roles for C1 Inhibitor in Transplantation |
Q37149537 | Pre-transplant antibodies to Kα1 tubulin and collagen-V in lung transplantation: clinical correlations |
Q59314345 | Precision Diagnostics in Transplantation: From Bench to Bedside |
Q91834605 | Prevalence of antibodies to lung self-antigens (Kα1 tubulin and collagen V) and donor specific antibodies to HLA in lung transplant recipients and implications for lung transplant outcomes: Single center experience |
Q47662940 | Prevention of chronic rejection after lung transplantation |
Q89600511 | Respiratory viral infection in lung transplantation induces exosomes that trigger chronic rejection |
Q42767292 | Soluble CD59 is a Novel Biomarker for the Prediction of Obstructive Chronic Lung Allograft Dysfunction After Lung Transplantation |
Q61814286 | The Autoimmune-Associated Single Nucleotide Polymorphism Within Correlates With Clinical Outcome After Lung Transplantation |
Q38877375 | The importance of non-HLA antibodies in transplantation |
Q27008934 | The role of autoimmunity in obliterative bronchiolitis after lung transplantation |
Q86564354 | Transplantation: Autoantibodies-epiphenomena or biological clues |
Q90747606 | Update on Bronchiolitis Obliterans Syndrome in Lung Transplantation |
Q64990845 | What Lies beneath: Preformed Autoantibodies and Lung Transplantation. |
Q47999795 | Zbtb7a induction in alveolar macrophages is implicated in anti-HLA-mediated lung allograft rejection. |
Search more.